Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients
Clinical trial NCT00316589 · COMPLETED
Trial details
- NCT number
- NCT00316589
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2009-03-01
- Enrollment
- 581
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.